Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nanobiotix S.A. - ADSs (NQ:NBTX)

23.48 -0.20 (-0.87%)
Delayed Quote Updated: 11:29 AM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nanobiotix S.A. - ADSs

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗
 
Via Benzinga
News headline image
NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer
From NANOBIOTIX
Via Business Wire
News headline image
NANOBIOTIX Co-Founder and CEO Laurent Levy Named to 2022 PharmaVoice 100 List of Most Inspiring People in Life Sciences
From NANOBIOTIX
Via Business Wire
News headline image
Nanobiotix to Present During the H.C. Wainwright Global Investment Conference in September 2022
From NANOBIOTIX
Via Business Wire
News headline image
NANOBIOTIX: Voting Rights and Shares Capital of the Company
From Nanobiotix
Via Business Wire
News headline image
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
  
Via Benzinga
News headline image
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million. 
Via Benzinga
News headline image
Half-year Report on the Nanobiotix Liquidity Contract With Gilbert Dupont
From Nanobiotix
Via Business Wire
News headline image
NANOBIOTIX: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
From Nanobiotix
Via Business Wire
News headline image
NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications
From NANOBIOTIX
Via Business Wire
News headline image
NANOBIOTIX Annual Shareholders’ General Meeting to Be Held on June 23, 2022
From Nanobiotix
Via Business Wire
News headline image
CORRECTING and REPLACING: NANOBIOTIX Provides First Quarter Operational and Financial Update
From Nanobiotix
Via Business Wire
News headline image
NANOBIOTIX Provides First Quarter Operational and Financial Update
From Nanobiotix
Via Business Wire
News headline image
NANOBIOTIX to Present During the Jefferies Healthcare Conference in June 2022
From Nanobiotix
Via Business Wire
News headline image
NANOBIOTIX to Participate in Two Upcoming Investor Conferences
From Nanobiotix
Via Business Wire
News headline image
7 Biotech Stocks With Key Catalysts for May ↗
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. 
Via InvestorPlace
News headline image
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
From Nanobiotix
Via Business Wire
News headline image
NANOBIOTIX to Announce First Quarter 2022 Financial Results on May 18, 2022
From NANOBIOTIX
Via Business Wire
News headline image
New Data Featuring NANOBIOTIX Lead Product Candidate NBTXR3 to Be Presented at the 2022 ASCO Annual Meeting
From NANOBIOTIX
Via Business Wire
News headline image
Nanobiotix's Radiotherapy Combo Therapy Shows Boosted Anti-Tumor Activity In Preclinical Studies ↗
Nanobiotix SA (NASDAQ: NBTX)  
Via Benzinga
News headline image
NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3
From NANOBOTIX
Via Business Wire
News headline image
NANOBIOTIX Announces Filing of the 2021 Universal Registration Document and the 2021 Annual Report on Form 20-F
From NANOBIOTIX
Via Business Wire
News headline image
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
From Nanobiotix
Via Business Wire
News headline image
NANOBIOTIX Provides Business Update and Reports Full Year 2021 Financial Results
From NANOBIOTIX
Via Business Wire
News headline image
NANOBIOTIX to Announce Full Year 2021 Financial Results on March 30, 2022
From NANOBIOTIX
Via Business Wire
News headline image
Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
From NANOBIOTIX
Via Business Wire
News headline image
Earnings Scheduled For March 30, 2022 ↗
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. 
Via Benzinga
News headline image
Nanobiotix Announces Publication of New Clinical Case Study Highlighting First Patient Experience of NBTXR3 Treatment for Pancreatic Cancer
From Nanobiotix
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.